Know Your Risk:
A new gene test is designed to predict if patients with Stage I or II melanoma are at high or low risk of their cancer spreading, based on their tumor biology.
Decide with your doctor if DecisionDx-Melanoma is right
Healthcare Professionals Only
Please leave this field empty.
March 20, 2017
January 23, 2017
November 14, 2016
We want to hear from you. Our team is available to answer questions about the test by phone or email.
Call us at 866-788-9007 or write to email@example.com.